Abstract

In oncology, complementary therapy aims to assist patients in better coping with their illness and treatmentrelated side effects (SEs) that impact their quality of life (QOL). The purpose of this study was to determine whether postsurgical complementary therapy patients with non-metastatic breast cancer (BC) who received homeopathic treatment improved their health-related quality of life (HRQOL). All patients who underwent a mastectomy for newly diagnosed BC between 2012 and 2013 were the focus of an extraction from the French national healthcare database. The amount of medication used to alleviate the SEs of cancer treatments was used as a proxy for HRQOL. Following a diagnosis of BC, a rise in the use of homeopathy was observed, according to the study. After surgery, this use continued, and it appeared to help patients better tolerate the side effects of cancer treatments.